Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2012; 18(1): 55-63
Published online Jan 7, 2012. doi: 10.3748/wjg.v18.i1.55
Published online Jan 7, 2012. doi: 10.3748/wjg.v18.i1.55
Table 5 Impact of age on the parameters at the end of therapy
| Parameters | Age > 39 yr(n=11) | Age < 39 yr(n=8) | P value |
| AST (U/L) | 32.91 | 30.25 | 0.82 |
| ALT (U/L) | 30.09 | 32.25 | 0.81 |
| HCV-RNA (log10 IU/mL) | 2.92 | 2.33 | 0.7 |
| WBC (109/L) | 4.28 | 6.04 | 0.53 |
| Hemoglobin (G/L) | 109.18 | 88.75 | 0.11 |
| Creatinine (Umol/L) | 148.73 | 124.63 | 0.46 |
| GFR (mL/min) | 67.73 | 68.88 | 0.92 |
- Citation: Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63
- URL: https://www.wjgnet.com/1007-9327/full/v18/i1/55.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i1.55